Alterations of the human gut microbiome in multiple sclerosis
Topçuolu, Begüm D.
MetadataShow full item record
CitationJangi, S., R. Gandhi, L. M. Cox, N. Li, F. von Glehn, R. Yan, B. Patel, et al. 2016. “Alterations of the human gut microbiome in multiple sclerosis.” Nature Communications 7 (1): 12015. doi:10.1038/ncomms12015. http://dx.doi.org/10.1038/ncomms12015.
AbstractThe gut microbiome plays an important role in immune function and has been implicated in several autoimmune disorders. Here we use 16S rRNA sequencing to investigate the gut microbiome in subjects with multiple sclerosis (MS, n=60) and healthy controls (n=43). Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas, and correlate with variations in the expression of genes involved in dendritic cell maturation, interferon signalling and NF-kB signalling pathways in circulating T cells and monocytes. Patients on disease-modifying treatment show increased abundances of Prevotella and Sutterella, and decreased Sarcina, compared with untreated patients. MS patients of a second cohort show elevated breath methane compared with controls, consistent with our observation of increased gut Methanobrevibacter in MS in the first cohort. Further study is required to assess whether the observed alterations in the gut microbiome play a role in, or are a consequence of, MS pathogenesis.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:27822118
- HMS Scholarly Articles